Darrin Lindhout

Darrin Lindhout, Ph.D. joined Lycia in September 2020 and currently is the Executive Director, Head of Biologics, providing leadership for their biologics and discovery research efforts. He was most recently Director, Protein Sciences at NGM Biopharmaceuticals (NASDAQ: NGM), where he spent 11+ years building the biologics capabilities. While at NGM, he directly contributed to seven IND candidates and was involved in protein engineering and research processes spanning metabolic, oncology and ophthalmology indications, resulting in more than 20 granted patents pertaining to protein structure/function. Prior to NGM, Darrin completed his post-doctoral research at Stanford University School of Medicine in the Department of Structural Biology in 2008 and received his Ph.D. in Biochemistry from the Department of Biochemistry at the University of Alberta in 2005.